|
AU5777801A
|
|
Pharmaceutical agent containing Rho kinase inhibitor
|
|
WO0195912A1
|
|
COMPOSITIONS CONTROLLING RELEASE pH RANGE AND/OR SPEED
|
|
WO0194311A1
|
|
Cytoprotectors
|
|
AU5676201A
|
|
Process for producing protein with reduction of acidic sugar chain and glycoprotein produced thereby
|
|
AU4878601A
|
|
Aromatic amide compounds
|
|
AU4435801A
|
|
Schizophrenia related genes
|
|
WO0168607A1
|
|
Amide compounds and use thereof
|
|
WO0166735A1
|
|
Mitf-associated proteins
|
|
WO0166546A1
|
|
Spiro compounds, process for preparing the same and use thereof as drugs
|
|
WO0164743A1
|
|
GPib-LIPID BOND CONSTRUCT AND USE THEREOF
|
|
CA2333217A1
|
|
Quality control material
|
|
AU2398801A
|
|
Virus-free plasma protein compositions treated with porous membrane and process for producing the same
|
|
AU7451200A
|
|
Analgesics
|
|
AU6869100A
|
|
Preventives or remedies for ischemic injury or ischemic reperfusion injury
|
|
JP2001055340A
|
|
Production of albumin preparation
|
|
US6288061B1
|
|
Imidazole derivatives
|
|
WO0078758A1
|
|
Novel imidazole derivatives
|
|
AU5250400A
|
|
Osteogenesis promoters
|
|
WO0076995A1
|
|
Process for the preparation of (-)-1,4-benzothiazine-2-acetic acid derivatives
|
|
JP2001340429A
|
|
Mixing injector for separating microorganism and stopper body using the same, and drug solution container with the stopper body
|
